30 Although the rate of symptomatic VTE was lower among apixaban-treated patients compared with enoxaparin-treated patients, this difference did not reach statistical significance.
← all excerpts
Reducing the burden of venous thromboembolism in the acute medically ill population with extended-duration thromboprophylaxis.
1
—
—